Skip to content

A study to evaluate the efficacy and safety of the test product on the tanned skin.

A clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female participants. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095413
Enrollment
36
Registered
2025-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CL-TRFW-25: Approx. 1 gm of product will be applied twice a week during the entire study duration. Control Intervention1: NIL: NIL

Sponsors

Zydus Wellness Products Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Non-pregnant /non-lactating females. 2) Participants with fitzpatrick skin type IV and V. 3) Participants with visible skin tan on face, at least 2 shade darker than a Sun protected upper volar arm. 4) Participants with visible blackheads on the face. 5) Participants with at least 2 blemishes. 6) Participants who are willing to voluntarily participate in the study and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Participants with dark facial skin as determined by dermatologist. 2) Participants having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments. 3) Participants using any other facewash during the study period. 4) Participants using other marketed skin lightening products during the study period or in the past 6 weeks. 5) Participants who are receiving topical or systemic treatments for pigmentation within the last 30 days. 6) Participant undergoing treatment for Seborrhoea, Acne, Dermatitis, Melasma, Lentigines, skin Lightening/ any other cosmetic/ dermatologic skin condition on face.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of test product on tanned skin, based on instrumental evaluations.Timepoint: Day 01 (Before and after product usage) , Day 03, Day 07, Day 14 and Day 21.

Secondary

MeasureTime frame
To assess the efficacy of test product on tanned skin, based on clinical, instrumental and subjective evaluations.Timepoint: Day 01 (Before and after product usage) , Day 03, Day 07, Day 14 and Day 21.

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

damori@cliantha.com9773262487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026